An infrequent but unpleasant adverse event of Tamsulosin

Abstract

Tamsulosin, a selective α1-adrenoceptor antagonist, is primarily approved for managing benign prostatic hyperplasia. Its off-label application in facilitating the spontaneous passage of ureteral stones, particularly in cases of renal colic, has gained traction in recent years. This report details a rare adverse effect of Tamsulosin observed in a young woman who was concurrently receiving atenolol for primary hypertension and was prescribed Tamsulosin following an episode of renal colic. Remarkably, after three doses, she developed severe constipation, a condition that necessitated manual interventions for resolution. Upon discontinuing Tamsulosin, her bowel function normalized. Given the localization of α1-adrenoceptors in the smooth muscles of intestinal sphincters, it is postulated that Tamsulosin's action, potentially compounded by atenolol's effects, contributed to this adverse reaction. This case underscores the importance of cautious prescribing and monitoring when utilizing Tamsulosin in contexts outside its primary indication. It highlights the intricate interplay between pharmacodynamics and individual patient factors in clinical settings.

Keywords

• α1-adrenergic receptor
• atenolol
• adverse event
• constipation
• tamsulosin